A CONCERTED push to stop Parkinson’s disease in its tracks is now underway, with researchers planning innovative programs to combine drug trials with genetic analyses to better target therapies.
Speaking to InSight+ ahead of World Parkinson’s Day on 11 April, Professor Simon Lewis, Professor of Cognitive Neuroscience at the University of Sydney’s Brain and Mind Centre, said the Federal Government’s announcement in January 2019 of $30 million funding over 5 years for the Australian Parkinson’s Mission provided a significant boost to efforts to halt or slow the progression of Parkinson’s disease.
The Mission is an Australian-led international collaboration, developed by the Garvan Institute of Medical Research, Shake It Up Australia Foundation, Parkinson’s Australia, the Cure Parkinson’s Trust and the Michael J Fox Foundation for Parkinson’s Research.
Professor Lewis, National Trials Leader for the Mission, said the first of a series of innovative disease-modifying drug trials would get underway in the coming months.
“I have been charged with leading a clinical effort to get a series of programs of disease-modifying trials where we can evaluate drugs that we think might stand a chance of doing something, but also link those trial findings with patients’ genetic analyses and other biomarkers that might allow us to pick the right drugs for the right patients in the future,” he said.
Read the entire post here: https://insightplus.mja.com.au/2019/13/push-to-stop-parkinsons-in-its-tracks/